PMID- 6794904 OWN - NLM STAT- MEDLINE DCOM- 19820120 LR - 20190720 IS - 0304-3835 (Print) IS - 0304-3835 (Linking) VI - 11 IP - 4 DP - 1981 Feb TI - Aminoguanidine reversal of the inhibitory effects of ornithine analogs on the in vitro clonogenic survival of the R3327AT prostate-derived tumor. PG - 323-30 AB - In in vitro studies with the Copenhagen rat prostate-derived tumor cell lines, the activity of ornithine decarboxylase (ODC) of these lines were as sensitive to inhibition by alpha-difluoromethylornithine (alpha-DFMO) as normal prostatic tissue. The in vitro growth of the tumor in calf serum was inhibited by ODC inhibitors alpha-methylornithine and alpha-difluoromethylornithine. This inhibition was partially reversed by the diamine oxidase inhibitor aminoguanidine. Further, alpha-DFMO was not inhibitory to the growth of these cells in sera which lacked diamine oxidase activity, but was inhibitory when diamine oxidase was added. FAU - Heston, W D AU - Heston WD FAU - Lazan, D W AU - Lazan DW FAU - Fair, W R AU - Fair WR LA - eng GR - CA23665/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - Ireland TA - Cancer Lett JT - Cancer letters JID - 7600053 RN - 0 (Guanidines) RN - 0 (Ornithine Decarboxylase Inhibitors) RN - E524N2IXA3 (Ornithine) RN - EC 1.4.3.21 (Amine Oxidase (Copper-Containing)) RN - EC 4.1.1.- (Carboxy-Lyases) RN - EC 4.1.1.17 (Ornithine Decarboxylase) RN - SCQ4EZQ113 (pimagedine) RN - V10TVZ52E4 (Putrescine) RN - ZQN1G5V6SR (Eflornithine) SB - IM MH - Amine Oxidase (Copper-Containing)/*antagonists & inhibitors/physiology MH - Animals MH - Carboxy-Lyases/*antagonists & inhibitors MH - Cell Line MH - Eflornithine MH - Guanidines/*pharmacology MH - Male MH - Ornithine/*analogs & derivatives/pharmacology MH - Ornithine Decarboxylase/analysis MH - *Ornithine Decarboxylase Inhibitors MH - Prostatic Neoplasms/*drug therapy/enzymology MH - Putrescine/pharmacology MH - Rats EDAT- 1981/02/01 00:00 MHDA- 1981/02/01 00:01 CRDT- 1981/02/01 00:00 PHST- 1981/02/01 00:00 [pubmed] PHST- 1981/02/01 00:01 [medline] PHST- 1981/02/01 00:00 [entrez] AID - 0304-3835(81)90098-7 [pii] AID - 10.1016/0304-3835(81)90098-7 [doi] PST - ppublish SO - Cancer Lett. 1981 Feb;11(4):323-30. doi: 10.1016/0304-3835(81)90098-7.